Department of Medicinal Chemistry, Roche Palo Alto LLC, 3431 Hillview Avenue, Palo Alto, CA 94304, USA.
Bioorg Med Chem Lett. 2010 Aug 15;20(16):4753-6. doi: 10.1016/j.bmcl.2010.06.135. Epub 2010 Jul 1.
The introduction of N-substituted pyrazoles in a new series of CCR5 antagonists was shown to substantially increase antiviral activity.
在一系列新的 CCR5 拮抗剂中引入 N-取代吡唑,可显著提高抗病毒活性。